No Data
Is China National Medicines Corporation Ltd.'s (SHSE:600511) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
China National Medicines Corporation Ltd.'s (SHSE:600511) Largest Shareholders Are Private Companies With 56% Ownership, Individual Investors Own 27%
China National Medicines Corporation (600511.SH): Chairman Jiang Xiuchang has retired and left office.
China National Medicines Corporation (600511.SH) announced that the board of directors recently received a submission from the company's chairman, Jiang Xiuchang, ...
Stocks are hitting the ceiling! Since October, 10 A-share listed companies have announced being targeted, with china national medicines corporation and sh pharma being targeted on the same day by new china life insurance.
① According to incomplete statistics, since October, 10 A-share listed companies including zhejiang east crystal electronic, semiconductor manufacturing international corporation, quanjinhao, lifecome biochemistry, zhejiang jingu, primeton information technologies, inc., guangzhou goaland energy conservation tech, xuzhou handler special vehicle, china national medicines corporation, and sh pharma have announced that they have received major stock purchases from relevant parties (see attached table). ② In the secondary market, this week, xuzhou handler special vehicle and guangzhou goaland energy conservation tech have both seen their stock prices increase by more than 100% since September.
Investors Don't See Light At End Of China National Medicines Corporation Ltd.'s (SHSE:600511) Tunnel
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
China National Medicines (SHSE:600511) Might Be Having Difficulty Using Its Capital Effectively
